Nephritogenic autoantibodies in systemic lupus
系统性狼疮中的肾炎性自身抗体
基本信息
- 批准号:9034312
- 负责人:
- 金额:$ 15.34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-02-25 至 2021-02-24
- 项目状态:已结题
- 来源:
- 关键词:AccountingActinsAddressAffectAmericanAnimal ModelAnnexinsAntibodiesAntigen TargetingAntigen-Antibody ComplexAttentionAutoantibodiesAutoimmune DiseasesAwardBiological MarkersCell physiologyCellsClinicalCytoskeletonDataDepositionDevelopmentDevelopment PlansDialysis procedureDisciplineDiseaseEnd stage renal failureEvaluationFiltrationFunctional disorderGoalsHistopathologyHumanImmunoglobulin GInflammatoryInflammatory ResponseInjection of therapeutic agentInjuryK-Series Research Career ProgramsKidneyKidney FailureKnowledgeLeadLifeLupusLupus NephritisMembranous GlomerulonephritisMentorsMentorshipNuclearNucleosomesPathogenesisPatientsPhysiciansPrognostic MarkerProteinsProteinuriaPublicationsRenal glomerular diseaseResearchRoleScientistSerumSystemic Lupus ErythematosusTestingTherapeutic immunosuppressionTimeTissuesTrainingTreatment ProtocolsValidationbasecareercareer developmentdiagnostic biomarkerdisease diagnosisds-DNAexperienceimprovedimproved outcomeinjuredlupus prone micemesangial cellmoesinmouse modelnovel diagnosticspodocyteprogramspublic health relevanceresearch studyskillstreatment response
项目摘要
DESCRIPTION (provided by applicant): Up to 60% of SLE patients develop clinical evidence of kidney injury, termed lupus nephritis (LN). LN is thought to be caused by glomerular immune complex deposition activating an inflammatory cascade that injures glomerular cells, leading to proteinuria and loss of filtration capacity. LN is classified based on renal histopathology into si classes, of which proliferative LN (ISN/RPS class III or IV) is most likely to cause renal failure.
Most studies examining the causes of proliferative LN have focused on the nephritogenic potential of anti-nuclear antibodies, diverting attention from a potential role for tissue/cell-specific autoantibodies. There is increasing evidence that autoantibodies to tissue specific target antigens contribute to the pathogenesis of many glomerular diseases, including LN. Our preliminary data show that sera from patients with proliferative LN contain autoantibodies to human glomerular proteins, including annexin A2 and moesin. These findings support our central hypothesis that autoantibodies targeting glomerular proteins, including annexin A2 and moesin, result in immune complex deposition that causes proliferative LN. This mentored career development proposal will focus on further characterization of autoantibodies to annexin A2 and moesin in proliferative LN, validation of those autoantibodies as biomarkers for disease, examination of the functional changes in podocytes and mesangial cells exposed to those autoantibodies, and evaluation of the nephritogenic potential of those antibodies in animal models. As evidenced by the advances in understanding primary membranous nephropathy after the identification of target antigens, this will lead to improved understanding of the pathogenic mechanisms of disease, and provide new diagnostic and prognostic biomarkers. This mentored career development award also will provide protected time for the applicant to develop the skills required to become an independent physician-scientist, investigating clinical and basic aspects of lupus nephritis, through an individualized career development plan which has been developed by the mentorship team.
描述(由申请人提供):高达60%的SLE患者出现肾损伤的临床证据,称为狼疮性肾炎(LN)。LN被认为是由肾小球免疫复合物沉积激活损伤肾小球细胞的炎性级联反应引起的,导致蛋白尿和滤过能力丧失。LN根据肾组织病理学分为SI类,其中增殖性LN(ISN/RPS III或IV类)最可能引起肾衰竭。
大多数研究增殖性LN的原因集中在抗核抗体的致肾炎潜力,转移注意力从组织/细胞特异性自身抗体的潜在作用。越来越多的证据表明,组织特异性靶抗原的自身抗体有助于许多肾小球疾病,包括LN的发病机制。我们的初步数据显示,增生性LN患者的血清中含有抗人肾小球蛋白的自身抗体,包括膜联蛋白A2和膜突蛋白。这些发现支持了我们的中心假设,即针对肾小球蛋白(包括膜联蛋白A2和膜突蛋白)的自身抗体导致免疫复合物沉积,导致增殖性LN。这个指导的职业发展建议将集中在增殖性LN中膜联蛋白A2和膜突蛋白的自身抗体的进一步表征,这些自身抗体作为疾病生物标志物的验证,暴露于这些自身抗体的足细胞和系膜细胞的功能变化的检查,以及这些抗体在动物模型中的致肾炎潜力的评估。正如在识别靶抗原后对原发性膜性肾病的理解的进展所证明的那样,这将导致对疾病的致病机制的更好理解,并提供新的诊断和预后生物标志物。该指导职业发展奖还将为申请人提供受保护的时间,以发展成为独立的医生科学家所需的技能,通过指导团队制定的个性化职业发展计划调查狼疮肾炎的临床和基本方面。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dawn Caster其他文献
Dawn Caster的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dawn Caster', 18)}}的其他基金
相似海外基金
A novel motility system driven by two classes of bacterial actins MreB
由两类细菌肌动蛋白 MreB 驱动的新型运动系统
- 批准号:
22KJ2613 - 财政年份:2023
- 资助金额:
$ 15.34万 - 项目类别:
Grant-in-Aid for JSPS Fellows
The structural basis of plasmid segregation by bacterial actins
细菌肌动蛋白分离质粒的结构基础
- 批准号:
342887 - 财政年份:2016
- 资助金额:
$ 15.34万 - 项目类别:
Operating Grants
The structural basis for plasmid segregation by bacterial actins
细菌肌动蛋白分离质粒的结构基础
- 批准号:
278338 - 财政年份:2013
- 资助金额:
$ 15.34万 - 项目类别:
Operating Grants
Cytoplasmic Actins in Maintenance of Muscle Mitochondria
细胞质肌动蛋白在维持肌肉线粒体中的作用
- 批准号:
8505938 - 财政年份:2012
- 资助金额:
$ 15.34万 - 项目类别:
Differential Expression of the Diverse Plant Actins
多种植物肌动蛋白的差异表达
- 批准号:
7931495 - 财政年份:2009
- 资助金额:
$ 15.34万 - 项目类别:
Studies on how actins and microtubules are coordinated and its relevancy.
研究肌动蛋白和微管如何协调及其相关性。
- 批准号:
19390048 - 财政年份:2007
- 资助金额:
$ 15.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Interaction of myosin with monomeric actins
肌球蛋白与单体肌动蛋白的相互作用
- 批准号:
5311554 - 财政年份:2001
- 资助金额:
$ 15.34万 - 项目类别:
Priority Programmes
STRUCTURE/INTERACTIONS OF ACTINS AND ACTIN-BINDING PROTEIN
肌动蛋白和肌动蛋白结合蛋白的结构/相互作用
- 批准号:
6316669 - 财政年份:2000
- 资助金额:
$ 15.34万 - 项目类别:














{{item.name}}会员




